Bacterial Vaginosis (BV)

What is Bacterial Vaginosis?

Bacterial Vaginosis (BV) is the most common vaginal condition affecting women of reproductive age in the United Kingdom. It occurs when there's an imbalance in the natural bacterial ecosystem of the vagina. Rather than being an infection caused by a single foreign pathogen, BV represents a shift in the balance of bacteria that normally live harmlessly in the vagina.

A healthy vagina naturally contains a delicate balance of different bacteria, predominantly Lactobacillus species. These "good" bacteria help maintain a slightly acidic environment (pH typically 3.8-4.5) that prevents the overgrowth of other microorganisms. In Bacterial Vaginosis, the number of Lactobacillus bacteria decreases, while other bacteria – particularly anaerobic bacteria like Gardnerella vaginalis – multiply excessively. This shift changes the vaginal environment to a less acidic state and leads to the characteristic symptoms of BV.

It's crucial to understand that Bacterial Vaginosis:

• Is not a sexually transmitted infection (STI): While sexual activity can influence BV risk, it's not classified as an STI and can occur in women who are not sexually active.
• Is very common: BV affects approximately 1 in 3 women in the UK at some point in their lives, making it more common than thrush.
• Can be asymptomatic: Up to 50% of women with BV may not experience any symptoms but can still have the bacterial imbalance.
• Often recurs: Many women experience recurrent episodes, with about half of treated women experiencing another episode within 12 months.

According to the NHS, BV is particularly common in women between 15 and 44 years old. While it's not usually serious, proper Bacterial Vaginosis treatment is important because untreated BV can increase the risk of complications including other infections, problems during pregnancy, and issues following gynaecological procedures.

What Causes Bacterial Vaginosis?

The exact cause of Bacterial Vaginosis isn't completely understood, but it's fundamentally linked to a disruption in the natural balance of vaginal bacteria. Rather than being caused by a single factor, BV typically results from a combination of influences that alter the vaginal microenvironment.

Microbiological Factors

These factors relate to the bacterial changes that characterise BV and are the primary target of Bacterial Vaginosis treatment.

• Bacterial Imbalance: The hallmark of BV is a reduction in protective Lactobacillus bacteria and an overgrowth of anaerobic bacteria including Gardnerella vaginalis, Atopobium vaginae, Prevotella species, and others.
• Biofilm Formation: Some BV-associated bacteria can form a biofilm – a protective layer that adheres to vaginal cells, making the bacteria more resistant to both natural defences and antibiotics.
• pH Changes: The reduction in Lactobacillus leads to decreased lactic acid production, causing the vaginal pH to rise from the normal acidic range (3.8-4.5) to above 4.5. This less acidic environment further encourages the growth of BV-associated bacteria.
• Enzyme Production: BV-associated bacteria produce enzymes like sialidases that break down protective components in vaginal fluid, facilitating bacterial attachment and biofilm formation.

Risk Factors and Triggers

While any woman can develop BV, certain factors increase susceptibility to the bacterial imbalance:

• Sexual Activity: Women with new sexual partners, multiple partners, or who have sex with women have higher BV rates. However, BV can occur in women who are not sexually active.
• Vaginal Douching: Douching disrupts the natural vaginal flora and is strongly associated with BV development. The NHS Sexual Health services strongly advise against douching.
• Natural Hormonal Changes: Fluctuations during the menstrual cycle, pregnancy, or menopause can affect vaginal pH and bacterial balance.
• Intrauterine Devices (IUDs): Some studies show a slightly increased BV risk in women using IUDs, possibly due to the string providing a surface for bacteria to adhere to.
• Smoking: Tobacco use is associated with higher BV rates, though the mechanism isn't fully understood.
• Ethnicity: BV is more common in women of African descent, though the reasons are unclear and may involve genetic, behavioural, or environmental factors.
• Antibiotic Use: Some antibiotics can reduce protective Lactobacillus, potentially triggering BV in susceptible women.

Common Misconceptions About Causes

It's important to clarify what doesn't cause BV:

• Poor Hygiene: BV is not caused by poor personal hygiene. In fact, excessive washing with perfumed products can disrupt the natural balance.
• Toilet Seats, Swimming Pools, or Bedding: BV cannot be caught from these sources.
• Specific Sexual Acts: While sexual activity influences risk, no specific sexual acts directly cause BV.

Understanding these factors helps in both prevention and effective Bacterial Vaginosis treatment, as addressing contributing factors can reduce recurrence rates.

What Are The Types of Bacterial Vaginosis?

While Bacterial Vaginosis isn't formally classified into distinct types in medical guidelines, clinicians often categorise it based on presentation patterns, recurrence frequency, and symptom profiles. Understanding these categories helps guide appropriate Bacterial Vaginosis treatment approaches.

Symptom-Based Presentations

Bacterial Vaginosis can also present with varying symptom patterns:

• Classic Presentation: Thin, greyish-white discharge with strong fishy odour, particularly noticeable after sex or during periods.
• Atypical Presentation: May include mild itching or irritation (though significant itching suggests possible thrush co-infection or other conditions).
• Minimal Symptom Presentation: Some women notice only slight changes in discharge or intermittent odour.

Special Considerations

Certain situations require specific Bacterial Vaginosis treatment approaches:

• Pregnancy-associated BV: Requires treatment due to potential complications including preterm birth.
• Post-menopausal BV: May require different considerations due to hormonal changes affecting the vaginal environment.
• BV in Women with HIV: May be more persistent and require more aggressive management.

Understanding which pattern of BV you're experiencing helps healthcare providers tailor the most effective Bacterial Vaginosis treatment strategy and manage expectations regarding treatment response and potential recurrence.

How Is Bacterial Vaginosis Diagnosed?

Accurate diagnosis is essential for effective Bacterial Vaginosis treatment. Healthcare professionals use standardised criteria, often in combination with diagnostic tests, to confirm BV and rule out other conditions with similar symptoms.

Clinical Diagnostic Criteria (Amsel Criteria)

The most commonly used method for diagnosing BV in clinical practice is the Amsel criteria, which requires at least three of the following four features:

1. Thin, Homogeneous Discharge: Milky or greyish discharge that evenly coats the vaginal walls, rather than being clumpy like thrush.
2. Vaginal pH > 4.5: Measured using pH paper applied to vaginal fluid. A raised pH is a key indicator of BV.
3. Positive Whiff Test: Addition of 10% potassium hydroxide (KOH) to vaginal discharge produces a characteristic fishy odour.
4. Clue Cells on Microscopy: Vaginal epithelial cells with borders obscured by adherent bacteria, visible under microscope examination.

Laboratory Diagnostic Methods

In addition to clinical assessment, several laboratory methods can aid diagnosis:

• Gram Stain (Nugent Score): Considered the gold standard for BV diagnosis. Vaginal fluid is stained and examined under microscope, scoring from 0-10 based on bacterial types present. A score of 7-10 indicates BV.
• OSOM BVBlue Test: Rapid test that detects elevated sialidase enzyme levels produced by BV-associated bacteria.
• DNA-based Tests: PCR tests that identify specific BV-associated bacteria, though these are not routinely used for diagnosis.
• Cultures: Not typically useful as Gardnerella vaginalis can be present in women without BV.

What to Expect During Diagnosis

When you visit a healthcare provider with suspected BV:

• Medical History: Discussion of symptoms, menstrual cycle, sexual activity, previous episodes, and any recent antibiotic use.
• Pelvic Examination: Visual inspection of the vagina and cervix to assess discharge characteristics.
• Sample Collection: Using a speculum, your healthcare provider will collect a sample of vaginal discharge for testing.
• pH Testing: Simple pH paper test performed immediately during the examination.
• Microscopy: Some clinics can examine the sample under a microscope during your visit for immediate results.

Differential Diagnosis

It's important to distinguish BV from other conditions with similar symptoms:

• Vaginal Thrush (Candidiasis): Typically causes thick, white discharge like cottage cheese with itching and soreness.
• Trichomoniasis: An STI causing frothy, yellow-green discharge with itching and discomfort.
• Desquamative Inflammatory Vaginitis: Rare condition causing purulent discharge and inflammation.
• Normal Physiological Discharge: Clear or white discharge that varies through the menstrual cycle.

How To Prevent Bacterial Vaginosis?

While Bacterial Vaginosis cannot always be prevented, understanding and addressing risk factors can significantly reduce recurrence frequency and severity. Preventive strategies focus on maintaining the natural balance of vaginal bacteria and avoiding practices that disrupt this delicate ecosystem.

Lifestyle and Hygiene Practices

These daily practices form the foundation of BV prevention and complement Bacterial Vaginosis treatment:

• Avoid Douching: The vagina is self-cleaning and does not require internal washing. Douching removes protective bacteria and can spread infections higher into the reproductive tract.
• Practice Gentle External Cleaning: Wash the vulva with warm water only or mild, unperfumed soap. Avoid harsh soaps, shower gels, bubble baths, and antiseptics.
• Wipe Front to Back: Always wipe from front to back after using the toilet to prevent spreading bacteria from the anal area to the vagina.
• Choose Breathable Clothing: Wear cotton underwear and avoid tight-fitting trousers or synthetic materials that create warm, moist environments where bacteria thrive.
• Change Wet Clothing Promptly: Change out of wet swimwear or exercise clothing as soon as possible.
• Limit Sanitary Product Use: Change tampons and pads regularly during menstruation, and consider using unscented products.

Sexual Health Considerations

Since sexual activity can influence BV risk, these strategies may help:

• Condom Use: While BV is not an STI, consistent condom use may help reduce BV recurrence for some women by minimising exposure to semen, which can alter vaginal pH.
• Good Genital Hygiene: Both partners should practice good genital hygiene, but avoid harsh soaps or products that could cause irritation.
• Urinate After Sex: Emptying your bladder after sexual intercourse may help flush out bacteria.
• Avoid Vaginal Lubricants with Irritants: Choose water-based, pH-balanced lubricants without glycerin, perfumes, or antibacterial agents.
• Consider Sexual Practices: Some evidence suggests that oral sex and sharing sex toys might contribute to BV transmission between female partners.

Dietary and Supplemental Approaches

While research is ongoing, some approaches may support vaginal health:

• Probiotics: Some studies suggest that oral or vaginal probiotics containing Lactobacillus strains may help maintain healthy vaginal flora and prevent BV recurrence.
• Balanced Diet: A nutritious diet supporting overall immune health may help maintain natural defences.
• Limit Sugar: Some women find that reducing sugar intake helps, though evidence is limited.

Medical Prevention Strategies

For women with recurrent BV, these medical approaches may be considered:

• Extended Treatment Courses: Some women benefit from longer antibiotic courses or suppressive therapy under medical supervision.
• Alternative Contraception: If you suspect your IUD contributes to recurrent BV, discuss alternative contraception options with your healthcare provider.
• Regular Screening: Women with frequent recurrences may benefit from regular check-ups even when asymptomatic.

Remember that while these strategies can reduce BV risk, they cannot guarantee prevention. Some women remain prone to BV despite excellent preventive practices. If you experience recurrent episodes, discuss long-term management strategies with your healthcare provider as part of your comprehensive Bacterial Vaginosis treatment plan.

How Is Bacterial Vaginosis Treated?

Effective Bacterial Vaginosis treatment typically involves prescription antibiotics that target the overgrowth of anaerobic bacteria while allowing restoration of healthy Lactobacillus populations. Treatment choice depends on factors like symptom severity, recurrence pattern, pregnancy status, and patient preference.

1. First-Line Antibiotic Treatments

These are the most commonly prescribed and evidence-based Bacterial Vaginosis treatment options:

• Metronidazole:
  • How it works: An antibiotic particularly effective against anaerobic bacteria associated with BV.
  • Available forms: Oral tablets (400mg twice daily for 5-7 days) or vaginal gel.
  • Effectiveness: Approximately 70-80% cure rate at one month post-treatment.
  • Important considerations: Avoid alcohol during treatment and for 48 hours after completion due to potential disulfiram-like reaction (severe nausea and vomiting).
• Zidoval Gel (Metronidazole Vaginal Gel):
  • How it works: Topical application of metronidazole directly to the affected area.
  • Application: One applicatorful intravaginally once or twice daily for 5 days.
  • Advantages: Lower systemic absorption than oral medication, reducing side effects and alcohol interaction risk.
  • Effectiveness: Similar to oral metronidazole with fewer systemic side effects.
• Dalacin Cream (Clindamycin Vaginal Cream):
  • How it works: Alternative antibiotic effective against BV-associated bacteria.
  • Application: One applicatorful intravaginally at bedtime for 3-7 days.
  • Advantages: Useful for women who cannot tolerate metronidazole or have treatment-resistant BV.
  • Important considerations: May weaken latex condoms and diaphragms during treatment and for several days after.

2. Treatment for Recurrent Bacterial Vaginosis

For women experiencing multiple BV episodes per year, more intensive Bacterial Vaginosis treatment strategies may be necessary:

• Extended Metronidazole Therapy: Oral metronidazole twice weekly for 4-6 months as suppressive therapy.
• Combination Therapy: Simultaneous use of oral and vaginal antibiotics, though evidence is limited.
• Alternative Regimens: Tinidazole (another nitroimidazole antibiotic) may be used in some cases.
• Adjunctive Probiotics: Some studies suggest combining antibiotics with specific probiotic strains may reduce recurrence rates.

3. Special Population Considerations

Certain situations require specific Bacterial Vaginosis treatment approaches:

• Pregnancy: BV treatment is recommended during pregnancy due to association with preterm birth and other complications. Metronidazole or clindamycin are considered safe after the first trimester.
• Breastfeeding: Both metronidazole and clindamycin are considered compatible with breastfeeding, though topical treatments are often preferred to minimise infant exposure.
• Allergies or Intolerances: Women allergic to metronidazole or clindamycin may require alternative treatments under specialist guidance.
• HIV-Positive Women: May require longer treatment courses due to higher recurrence rates.

4. Adjunctive and Supportive Treatments

While antibiotics remain the primary Bacterial Vaginosis treatment, some supportive approaches may help:

• Vaginal Acidifying Gels: Products that help restore normal vaginal pH may provide symptomatic relief and support treatment.
• Probiotic Supplements: Specific strains of oral or vaginal Lactobacillus may help restore healthy flora.
• Boric Acid Suppositories: Sometimes used for recurrent or treatment-resistant BV, though not licensed for this use in the UK.

Treatment Expectations and Follow-up

When undergoing Bacterial Vaginosis treatment:

• Symptom Improvement: Symptoms typically improve within 2-3 days of starting treatment.
• Completion of Course: Always complete the full antibiotic course even if symptoms resolve earlier.
• Follow-up: Routine test-of-cure is not recommended for asymptomatic women after treatment.
• Recurrence Management: If symptoms recur, consult your healthcare provider rather than self-treating with leftover medication.

It's essential to use Bacterial Vaginosis treatment under medical supervision to ensure correct diagnosis, appropriate medication selection, and monitoring for potential side effects or treatment failure.

Where Can I Buy Bacterial Vaginosis Treatment Online in the UK

Frequently Asked Questions (FAQs)